RK

Reena Kushwa

Director Director DIN 00128786
DIN 00128786 First appointment Jun 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Reena Kushwa

Data last updated:

Reena Kushwa was a Director at Omish Pharmaceuticals Private Limited (2006–2007) and Director at Omnac Pharmaceuticals Private Limited (from 2007). The companies operate in Pharma.

DIN 00128786
Primary Designation Director
Industry Pharma
First Appointment 14 Jun 2006
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jun 20062006₹2.4 Lakh (FY 2023)Strike Off
Director23 Mar 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Omnac Pharmaceuticals Private Limited
Omish Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reena Kushwa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Kushwa

Reena Kushwa was first appointed on 14 Jun 2006 as Director at Omish Pharmaceuticals Private Limited. The most recent appointment on record is 23 Mar 2007 at Omnac Pharmaceuticals Private Limited.

Reena Kushwa held 2 earlier board appointments: Omish Pharmaceuticals Private Limited (Director, 14 Jun 2006 to 02 Mar 2007); Omnac Pharmaceuticals Private Limited (Director, from 23 Mar 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available